Pharmacogenomics logo Future Medicine logo

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.

Publisher: Future Medicine

More about this publication?
Related content
Volume 10, Number 11, November 2009

< previous issue | all issues | next issue >

Editorial

News & Views

Research Highlights
pp. 1737-1741(5)
Authors: Müüller, Daniel J; Sturgess, Jessica E

Research Article

Common genetic variation in the ABCB1 gene is associated with the cholesterol-lowering effect of simvastatin in males
pp. 1743-1751(9)
Authors: Becker, Matthijs L; Visser, Loes E; van Schaik, Ron HN; Hofman, Albert; Uitterlinden, Andréé G; Stricker, Bruno HCh

Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian--Caucasian population: differences in enzyme activity
pp. 1753-1765(13)
Authors: Serpe, Loredana; Calvo, Pier Luigi; Muntoni, Elisabetta; D''Antico, Sergio; Giaccone, Mario; Avagnina, Alessandra; Baldi, Maurizio; Barbera, Cristiana; Curti, Franco; Pera, Angelo; Eandi, Mario; Zara, Gian Paolo; Canaparo, Roberto

Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis
pp. 1767-1779(13)
Authors: Kim, Sang-Heon; Kim, Sang-Hoon; Bahn, Joon-Woo; Kim, Yoon-Keun; Chang, Yoon-Seok; Shin, Eun-Soon; Kim, Youn-Seup; Park, Jae-Seuk; Kim, Bo-Hyung; Jang, In-Jin; Song, Junghan; Kim, Seung-Hyun; Park, Hae-Sim; Min, Kyung-Up; Jee, Young-Koo

Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas
pp. 1781-1787(7)
Authors: Ragia, Georgia; Petridis, Ioannis; Tavridou, Anna; Christakidis, Dimitrios; Manolopoulos, Vangelis G

Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension
pp. 1789-1797(9)
Authors: Wilke, Russell A; Simpson, Robert U; Mukesh, Bickol N; Bhupathi, Satya V; Dart, Richard A; Ghebranious, Nader R; McCarty, Catherine A

Review

Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations
pp. 1799-1817(19)
Authors: Ellis, Kyle J; Stouffer, George A; McLeod, Howard L; Lee, Craig R

Host genetic determinants of spontaneous hepatitis C clearance
pp. 1819-1837(19)
Authors: Rauch, Andri; Gaudieri, Silvana; Thio, Chloe; Bochud, Pierre-Yves

Pharmacogenomics in acute myeloid leukemia
pp. 1839-1851(13)
Authors: Roumier, Christophe; Cheok, Meyling H

Special Report

Survey on warfarin pharmacogenetic testing among anticoagulation providers
pp. 1853-1860(8)
Authors: Kadafour, Maha; Haugh, Roshanak; Posin, Monica; Kayser, Steven R; Shin, Jaekyu

Acknowledgements

Acknowledgements
pp. 1880-1880(1)

Erratum

Erratum
pp. 1882-1882(1)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page